Holen Sie sich die Stockscreener-App
14.87
2.13%
0.31
Handel nachbörslich:
14.80
-0.07
-0.47%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt FMC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$14.56
Offen:
$14.78
24-Stunden-Volumen:
1.96M
Relative Volume:
0.50
Marktkapitalisierung:
$1.86B
Einnahmen:
$3.43B
Nettoeinkommen (Verlust:
$-2.46B
KGV:
-0.7428
EPS:
-20.0187
Netto-Cashflow:
$-204.10M
1W Leistung:
-2.56%
1M Leistung:
-16.23%
6M Leistung:
+11.30%
1J Leistung:
-58.59%
1-Tages-Spanne:
$14.50
$15.15
1-Wochen-Bereich:
$14.50
$16.40
52-Wochen-Spanne:
$12.17
$44.78
Fmc Corp Stock (FMC) Company Profile
Firmenname
Fmc Corp
Sektor
Branche
Telefon
215-299-6668
Adresse
2929 WALNUT STREET, PHILADELPHIA, PA
Compare FMC vs CTVA, NTR, CF, MOS, ICL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FMC
Fmc Corp
|
14.87 | 1.82B | 3.43B | -2.46B | -204.10M | -20.02 |
CTVA
Corteva Inc
|
83.90 | 54.84B | 17.40B | 1.20B | 2.82B | 1.5836 |
NTR
Nutrien Ltd
|
77.24 | 36.48B | 26.89B | 2.30B | 2.01B | 4.6618 |
CF
Cf Industries Holdings Inc
|
128.04 | 19.34B | 7.08B | 1.80B | 1.80B | 8.9928 |
MOS
Mosaic Company
|
23.26 | 7.30B | 12.05B | 575.40M | -534.60M | 1.6871 |
ICL
Icl Group Ltd
|
5.60 | 7.14B | 7.15B | 280.00M | 137.88M | 0.1749 |
Fmc Corp Stock (FMC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-22 | Herabstufung | Vertical Research | Hold → Sell |
| 2025-12-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-11-11 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-10-31 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-10-31 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-10-30 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-10-14 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2025-06-23 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-25 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2025-02-14 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-07 | Herabstufung | UBS | Buy → Neutral |
| 2025-02-05 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-21 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-01-14 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-23 | Eingeleitet | Citigroup | Neutral |
| 2024-06-26 | Eingeleitet | Barclays | Equal Weight |
| 2024-03-01 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-02-12 | Herabstufung | Loop Capital | Buy → Hold |
| 2024-02-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2024-01-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-01-04 | Eingeleitet | ROTH MKM | Buy |
| 2023-12-14 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-12-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2023-10-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-10-24 | Herabstufung | Goldman | Buy → Neutral |
| 2023-10-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-10-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-09-25 | Herabstufung | Redburn Atlantic | Overweight → Neutral |
| 2023-09-05 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-21 | Eingeleitet | JP Morgan | Neutral |
| 2023-08-04 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2023-07-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-17 | Hochstufung | Redburn | Neutral → Buy |
| 2023-01-19 | Fortgesetzt | Wells Fargo | Overweight |
| 2023-01-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-07-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-06-21 | Hochstufung | BofA Securities | Underperform → Buy |
| 2022-06-13 | Herabstufung | Redburn | Buy → Neutral |
| 2022-05-31 | Eingeleitet | Credit Suisse | Underperform |
| 2022-04-14 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-03-31 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
| 2022-03-22 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-02-10 | Bestätigt | Citigroup | Buy |
| 2022-02-10 | Bestätigt | Mizuho | Buy |
| 2022-02-10 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2022-02-10 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-31 | Eingeleitet | Redburn | Buy |
| 2022-01-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-29 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-10-18 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-24 | Herabstufung | Vertical Research | Buy → Hold |
| 2021-05-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-02-11 | Hochstufung | Monness Crespi & Hardt | Neutral → Buy |
| 2020-09-17 | Eingeleitet | UBS | Buy |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-10-16 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-10-16 | Eingeleitet | Wells Fargo | Outperform |
| 2019-09-18 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2019-08-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-08-02 | Hochstufung | Goldman | Neutral → Buy |
| 2019-08-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-13 | Fortgesetzt | Citigroup | Buy |
| 2019-05-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2019-04-18 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-03-21 | Bestätigt | Jefferies | Buy |
| 2019-03-08 | Fortgesetzt | Goldman | Neutral |
| 2018-11-14 | Eingeleitet | Buckingham Research | Buy |
| 2018-11-09 | Fortgesetzt | Loop Capital | Buy |
| 2018-11-05 | Fortgesetzt | Citigroup | Buy |
| 2018-11-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2018-05-14 | Hochstufung | Goldman | Neutral → Buy |
| 2018-05-04 | Hochstufung | Stephens | Equal-Weight → Overweight |
Alle ansehen
Fmc Corp Aktie (FMC) Neueste Nachrichten
FMC Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
FMC Corp stock rises — what did the CEO say to drive rally? - MSN
FMC Corp. stock underperforms Monday when compared to competitors - MarketWatch
BMO reiterates FMC stock rating on 2026 guidance, asset sale plans - Investing.com India
FMC director Barry buys $249,938 in company stock - Investing.com
FMC Corporation (NYSE:FMC) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat
FMC Should I Buy - Intellectia AI
FMC Corp’s Forward-Looking Statements Pose Transparency and Risk Assessment Challenges for Investors - The Globe and Mail
FMC Annual Meeting Highlights 2025 Results, Cost Cuts, and Strategic Alternatives Review - MarketBeat
FMC (FMC) Gets a Hold from BMO Capital - The Globe and Mail
Analysts’ Top Materials Picks: FMC (FMC), Air Products and Chemicals (APD) - The Globe and Mail
Analysts Offer Insights on Materials Companies: FMC (FMC) and West Fraser Timber Co (WFG) - The Globe and Mail
BofA Securities Maintains FMC Corp(FMC.US) With Hold Rating - 富途牛牛
Columbia Variable PortfolioSelect Mid Cap Value Fund's FMC Corp(FMC) Holding History - GuruFocus
FMC Corp (FMC) Shares Fall 3.6% -- What GF Score of 55 Tells Inv - GuruFocus
FMC Corp Earnings Call Balances Progress And Strain - The Globe and Mail
FMC Maintained by JP Morgan -- Price Target Raised to $16.00 - GuruFocus
FMC analysts boost their forecasts following better-than-expected Q2 results - MSN
FMC Corp. stock underperforms Friday when compared to competitors - MarketWatch
FMC (NYSE:FMC) Given New $17.00 Price Target at Citigroup - MarketBeat
FMC Analysts Boost Their Forecasts Following Better-Than-Expected Q2 ResultsFMC (NYSE:FMC) - Benzinga
FMC (NYSE:FMC) Price Target Raised to $16.00 at JPMorgan Chase & Co. - MarketBeat
FMC Corporation Is Maintained at Neutral by JP Morgan - Moomoo
RBC Capital Maintains FMC Corp(FMC.US) With Hold Rating, Raises Target Price to $17 - Moomoo
J.P. Morgan Maintains FMC Corp(FMC.US) With Hold Rating, Announces Target Price $16 - 富途牛牛
A Quick Look at Today's Ratings for FMC Corp(FMC.US), With a Forecast Between $17 to $21 - Moomoo
FMC Corporation (NYSE:FMC) Q1 2026 Earnings Call Transcript - Insider Monkey
Citi Maintains FMC Corp(FMC.US) With Hold Rating, Raises Target Price to $17 - Moomoo
FMC SEC FilingsFmc Corp 10-K, 10-Q, 8-K Forms - Stock Titan
RBC Capital raises FMC stock price target to $17 on debt plan - Investing.com India
FMC Corp (FMC) Q1 2026 Earnings Call Highlights: Navigating Chal - GuruFocus
FMC Corp (FMC) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives By GuruFocus - Investing.com Canada
MSN Money - MSN
Goldman Sachs reiterates Buy on FMC stock after Q1 beat By Investing.com - Investing.com India
FMC SWOT Analysis: Significant Losses and Strategic Restructurin - GuruFocus
Goldman Sachs reiterates Buy on FMC stock after Q1 beat - Investing.com
FMC (FMC) Q1 2026 Earnings Call Transcript - The Globe and Mail
FMC Corp. stock outperforms competitors on strong trading day - MarketWatch
Director Michael F. Barry receives 9,175-share FMC (FMC) stock grant, lifting holdings - Stock Titan
FMC (NYSE: FMC) director granted 9,175 common shares in award - Stock Titan
FMC Corp | 4: Statement of changes in beneficial ownership of securities-Director Raines John Mitchell - Moomoo
[Form 4] FMC CORP Insider Trading Activity - Stock Titan
FMC Corp | 4: Statement of changes in beneficial ownership of securities-Director Pallash Robert C - Moomoo
18,843 FMC (NYSE: FMC) shares withheld to cover director tax - Stock Titan
FMC (NYSE: FMC) director uses 680 shares to cover stock tax liability - Stock Titan
FMC Corp | 4: Statement of changes in beneficial ownership of securities-Director MERKT STEVEN T - Moomoo
FMC Corp (FMC) director granted 9,175 common shares - Stock Titan
Director Johnson granted 9,175 FMC (NYSE: FMC) shares - Stock Titan
FMC (NYSE: FMC) director uses 1,032 shares for tax withholding - Stock Titan
Director at FMC (NYSE: FMC) awarded 9,175 shares in stock grant - Stock Titan
FMC (FMC) director receives 9,175-share equity grant, now holds 32,491 - Stock Titan
Finanzdaten der Fmc Corp-Aktie (FMC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):